PLYMOUTH MEDICAL

PLYMOUTH MEDICAL is a 2011-founded organization specializing in Orthobiologics and Regenerative Medicine, offering a diverse portfolio of evidence-based products catering to various medical specialties. Their range includes EmCyte™ Platelet Rich Plasma (PRP), EmCyte™ Bone Marrow Concentrate (BMC), EmCyte™ Plasma Concentrate (A2M), and several other innovative solutions. The company targets Orthopedics, Sports Medicine, Pain Management, Dermatology, Plastics, Esthetics, Urology, and OBGYN providers. Operating from its headquarters in Brooklyn, New York, PLYMOUTH MEDICAL prides itself on establishing lasting customer relationships and enhancing its product catalogue through its network of experienced healthcare professionals. While there is no public record of the latest investment and investors, the company's focus on evidence-based, high-impact medical solutions positions it favorably in the Health Care, Medical Devices, and Marketing industries.